SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77502.12
579.48 (0.75%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
91	Poly Medicure Ltd.	Q V PT	17,614 Small Cap	1,737.80 (4.38%)	52.43	5.77	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Procter & Gamble Health Ltd.	Q V+ PT	10,725 Small Cap	6,461.25 (1.86%)	32.81	20.45	4.31	11.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Rainbow Childrens Medicare Ltd.	Q V PT	14,449 Small Cap	1,422.60 (0.11%)	57.79	8.55	15.91	24.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	RPG Life Sciences Ltd.	Q V+ PT	3,958 Small Cap	2,393.10 (1.89%)	34.37	6.54	11.71	30.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	Rubicon Research Ltd.	Q V+ PT	22,733 Small Cap	1,374.55 (0.53%)	120.81	16.8	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Sai Life Sciences Ltd.	Q V+ PT	26,284 Small Cap	1,238.15 (-0.38%)	76.97	10.48	17.75	11.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,664 Small Cap	4,630.20 (0.40%)	41.35	23.6	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	Sanofi India Ltd.	Q V PT	8,006 Small Cap	3,476.10 (0.59%)	25.84	10.26	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	Senores Pharmaceuticals Ltd.	Q V+ PT	6,152 Small Cap	1,335.85 (1.50%)	303.81	8.2	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	Shalby Ltd.	Q V PT	1,873 Small Cap	173.45 (-0.69%)	16.59	1.5	12.52	25.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	Shilpa Medicare Ltd.	Q V+ PT	11,752 Small Cap	600.85 (5.26%)	48.29	4.54	7.22	-12.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	Shree Ganesh Remedies Ltd.	Q V PT	825 Small Cap	642.40 (-4.38%)	46.4	5.06	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	Sigachi Industries Ltd.	Q V+ PT	879 Small Cap	23 (-1.96%)	N/A	1.85	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	SMS Pharmaceuticals Ltd.	Q V+ PT	3,910 Small Cap	417.50 (1.93%)	44.63	4.86	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Solara Active Pharma Sciences Ltd.	Q V PT	2,759 Small Cap	571.85 (0.72%)	N/A	2.19	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Strides Pharma Science Ltd.	Q V+ PT	10,380 Small Cap	1,126.10 (2.76%)	56.52	3.16	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	7,759 Small Cap	239.10 (0.65%)	5	5.82	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,49,048 Large Cap	1,871.55 (0.30%)	39.12	5.37	9.87	23.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Supriya Lifescience Ltd.	Q V+ PT	8,004 Small Cap	994.55 (-1.46%)	38.28	6.68	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Suraksha Diagnostic Ltd.	Q V PT	1,413 Small Cap	271.30 (1.17%)	43.9	5.77	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Suven Life Sciences Ltd.	Q V+ PT	7,884 Small Cap	298.65 (8.92%)	N/A	5.24	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Syncom Formulations (India) Ltd.	Q V PT	1,340 Small Cap	14.25 (-1.18%)	17.62	3.25	17.63	21.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	Syngene International Ltd.	Q V+ PT	17,755 Small Cap	439.85 (1.92%)	58.23	3.77	10.89	4.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	Tarsons Products Ltd.	Q V+ PT	1,416 Small Cap	266.05 (1.78%)	62.47	2.1	12.30	-1.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Themis Medicare Ltd.	Q V PT	1,097 Small Cap	119.15 (7.73%)	N/A	4.09	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	Thyrocare Technologies Ltd.	Q V+ PT	8,863 Small Cap	556.85 (2.35%)	54.24	15.31	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,57,804 Large Cap	4,662.60 (0.45%)	72.94	18.81	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	Unichem Laboratories Ltd.	Q V PT	3,263 Small Cap	463.40 (-2.21%)	20.53	1.25	13.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,395 Small Cap	1,399 (2.27%)	83.22	15.04	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	Vimta Labs Ltd.	Q V+ PT	2,619 Small Cap	586.10 (0.47%)	33.79	5.82	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	298.65	8.92%
Themis Medicare	119.15	7.73%
Dishman Carbogen Amc	188	7%
Shilpa Medicare	600.85	5.26%
GPT Healthcare	156.45	4.40%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
KMC Speciality Hosp.	133.60	-5.01%
Morepen Laboratories	59.71	-4.63%
Fischer Medical	39.08	-4.59%
Shree Ganesh Remed.	642.40	-4.38%
Gufic Biosciences	385.40	-2.24%

News about Top Pharma Companies in India

Jul, 2026

Themis Medicare informs about disclosure

Themis Medicare has informed that the exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Vimta Labs informs about closure of trading window

Vimta Labs has informed that as per the provisions of the Company’s code of conduct for prevention of Insider Trading, the Trading Window for transactions in shares of the Company for all designated persons, their immediate relatives and all connected persons under the code will remain closed from 1stJuly 2026 till 48 hours post declaration of unaudited financial results of the Company for the first quarter ended 30th June 2026.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Shilpa Medicare informs about disclosure

Pursuant to Regulation 30 read with other applicable provisions of the SEBI Listing Regulations, Shilpa Medicare has informed that Shilpa Biologicals (SBPL), a wholly owned subsidiary of the Company, has entered into Co-development and supply agreement with Orion Corporation (‘Orion’) a globally recognized pharmaceutical company headquartered in Finland. Details with respect to the above-mentioned event as required under Regulation 30 of Schedule Ill of the SEBI Listing Regulations and SEBI Circular dated 30th January 2026 are provided in Annexure I to this letter. A press release to be issued in relation to the above matter is enclosed.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Shilpa Medicare’s arm commissions Antibody-Drug Conjugate GMP manufacturing facility

This commissioning marks a significant evolution of Shilpa Medicare’s over 25 years of deep-rooted expertise in highly potent compound manufacturing

Jun, 2026

Shilpa Medicare informs about press release

Shilpa Medicare has informed that it enclosed a press release on announcement of commissioning of a state-of-art Antibody–Drug Conjugate (ADC) GMP Manufacturing Facility by Shilpa Biologicals, a material subsidiary of the company. The above information is also available on the website of the Company www.vbshilpa.com.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Tarsons Products informs about trading window closure

Tarsons Products has informed that in terms of the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of Tarsons Products (the Company) will remain closed for all Designated Persons and their immediate relatives with effect from Wednesday, July 01, 2026 until 48 hours after the declaration and dissemination of the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. Accordingly, all the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of the Trading Window.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	3B Blackbio Dx Ltd.	1,037 Crore
2	Aarti Drugs Ltd.	3,502 Crore
3	Aarti Pharmalabs Ltd.	6,336 Crore
4	Abbott India Ltd.	54,657 Crore
5	Acutaas Chemicals Ltd.	30,212 Crore
6	Advanced Enzyme Technologies Ltd.	3,512 Crore
7	Ajanta Pharma Ltd.	41,776 Crore
8	Akums Drugs & Pharmaceuticals Ltd.	10,027 Crore
9	Alembic Pharmaceuticals Ltd.	16,024 Crore
10	Alivus Life Sciences Ltd.	14,232 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,722	54,657	35.22	11.45	24.04	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	72.94	18.81	38.40	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	39.56	9.23	26.73	25.35
Lupin Ltd. (M)	Somewhat Good	2,399	1,09,676	20.57	4.89	11.90	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,09,691	21.76	4.22	13.36	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,525	82,399	101
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	37,225	41.28
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	39.25
Aurobindo Pharma Ltd. (M)	Very Good	1,560	89,762	34.75
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	31.18
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	37,225	55.22	9.22	33.44	15.51
Mankind Pharma Ltd. (M)	Very Good	2,487	1,02,729	50.42	6.27	31.67	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	39.56	9.23	26.73	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,12,368	26.78	2.98	14.95	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	72.94	18.81	38.40	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,09,691	21.76	4.22	13.36	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,872	4,49,048	39.12	5.37	22.41	23.50
Abbott India Ltd. (M)	Very Good	25,722	54,657	35.22	11.45	24.04	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,12,368	26.78	2.98	14.95	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,195	61,943	45.48	5.89	12.07	14.41

You have 6 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Themis Medicare informs about disclosure

Vimta Labs informs about closure of trading window

Shilpa Medicare informs about disclosure

Shilpa Medicare’s arm commissions Antibody-Drug Conjugate GMP manufacturing facility

Shilpa Medicare informs about press release

Tarsons Products informs about trading window closure

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.